These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15505004)

  • 1. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
    Stern MP; Williams K; González-Villalpando C; Hunt KJ; Haffner SM
    Diabetes Care; 2004 Nov; 27(11):2676-81. PubMed ID: 15505004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study.
    Resnick HE; Jones K; Ruotolo G; Jain AK; Henderson J; Lu W; Howard BV;
    Diabetes Care; 2003 Mar; 26(3):861-7. PubMed ID: 12610050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study.
    Wannamethee SG
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S25-9. PubMed ID: 18469839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.
    Wilson PW; D'Agostino RB; Parise H; Sullivan L; Meigs JB
    Circulation; 2005 Nov; 112(20):3066-72. PubMed ID: 16275870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.
    Sattar N; McConnachie A; Shaper AG; Blauw GJ; Buckley BM; de Craen AJ; Ford I; Forouhi NG; Freeman DJ; Jukema JW; Lennon L; Macfarlane PW; Murphy MB; Packard CJ; Stott DJ; Westendorp RG; Whincup PH; Shepherd J; Wannamethee SG
    Lancet; 2008 Jun; 371(9628):1927-35. PubMed ID: 18501419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
    Meigs JB; Wilson PW; Nathan DM; D'Agostino RB; Williams K; Haffner SM
    Diabetes; 2003 Aug; 52(8):2160-7. PubMed ID: 12882936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.
    Guzder RN; Gatling W; Mullee MA; Byrne CD
    Diabetologia; 2006 Jan; 49(1):49-55. PubMed ID: 16341841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
    Lorenzo C; Okoloise M; Williams K; Stern MP; Haffner SM;
    Diabetes Care; 2003 Nov; 26(11):3153-9. PubMed ID: 14578254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.
    Wild SH; Byrne CD; Smith FB; Lee AJ; Fowkes FG
    Diabetes Care; 2006 Mar; 29(3):637-42. PubMed ID: 16505519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study.
    Petkeviciene J; Klumbiene J; Kriaucioniene V; Raskiliene A; Sakyte E; Ceponiene I
    BMC Public Health; 2015 Mar; 15():218. PubMed ID: 25880559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
    Stern MP; Williams K; Hunt KJ
    Atheroscler Suppl; 2005 May; 6(2):3-6. PubMed ID: 15823490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Scott R; O'Brien R; Fulcher G; Pardy C; D'Emden M; Tse D; Taskinen MR; Ehnholm C; Keech A;
    Diabetes Care; 2009 Mar; 32(3):493-8. PubMed ID: 18984774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting future cardiovascular disease: do we need the oral glucose tolerance test?
    Stern MP; Fatehi P; Williams K; Haffner SM
    Diabetes Care; 2002 Oct; 25(10):1851-6. PubMed ID: 12351490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
    Worm SW; Sabin CA; Reiss P; El-Sadr W; Monforte Ad; Pradier C; Thiebaut R; Law M; Rickenbach M; De Wit S; Lundgren JD; Friis-Møller N
    Diabetes Care; 2009 Mar; 32(3):474-80. PubMed ID: 19056612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.